Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze MLTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MLTX investment potential.

What is MLTX stock price today?

Get real-time MLTX stock price, historical data, and price charts on Financhill. Track MLTX performance with our advanced analysis tools.

Is MLTX a good investment?

Evaluate MLTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MLTX stock?

To buy MLTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MLTX?

View detailed market capitalization data and company valuation metrics for MLTX on our comprehensive analysis page.

What is the P/E ratio of MLTX?

Use our fundamental analysis tools to view MLTX P/E ratio and compare valuation metrics with industry peers.

What are MLTX earnings?

View MLTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

MoonLake Immunotherapeutics Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

MLTX
MoonLake Immunotherapeutics

Last Price:

$13.38

Seasonality Move:

20.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Share Price Moved. Momentum Hasn't Slowed.

MoonLake Immunotherapeutics Stock Forecast

Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 92.6% based on the past 5 years of stock performance.
MoonLake Immunotherapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Is MoonLake Immunotherapeutics Stock Undervalued?

The current MoonLake Immunotherapeutics [MLTX] share price is $13.39. The Score for MLTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
MLTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will MoonLake Immunotherapeutics Stock Go Up Next Year?

Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 92.6% based on the past 5 years of stock performance.

MoonLake Immunotherapeutics Stock Rating

Sell

MoonLake Immunotherapeutics (MLTX) is a Sell

Is MoonLake Immunotherapeutics overpriced?

MoonLake Immunotherapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

MoonLake Immunotherapeutics Stock Price History

Is MLTX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Switzerland

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

moonlaketx.com

52-Week Data

52-Week High:

62.75

52-Week Low:

5.95

Prediction Charts

Market Cap:

948.6M

Price in USD:

13.39

Volume:

1.1M

Beta:

1.10

Technical Analysis

SMA50:

12.01

SMA100:

29.21

SMA200:

35.93

52-Wk Change:

-74.19%

Stock Predictions

Is MoonLake Immunotherapeutics stock public?

Yes, MoonLake Immunotherapeutics is a publicly traded company.
What is the MoonLake Immunotherapeutics stock quote today?

The MoonLake Immunotherapeutics stock price is 13.39 USD today.
How to buy MoonLake Immunotherapeutics stock online?

You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-2	13.12	12.52	13.22	12.48
Dec-3	12.58	13.35	13.56	12.49
Dec-4	13.39	15.00	15.25	13.35
Dec-5	15.08	14.90	15.34	14.84
Dec-8	14.91	15.07	15.56	14.71
Dec-9	14.96	14.55	15.05	14.10
Dec-10	14.64	14.61	14.83	14.22
Dec-11	14.44	14.07	14.58	13.87
Dec-12	14.24	14.79	14.98	14.10
Dec-15	14.79	14.32	14.79	14.29
Dec-16	14.26	15.34	15.36	14.26
Dec-17	15.34	13.95	15.40	13.81
Dec-18	13.94	13.26	14.14	13.14
Dec-19	13.32	13.39	13.51	13.09

MoonLake Immunotherapeutics Earnings

MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

MoonLake Immunotherapeutics Forecast Revenue Growth

MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.86 per share, and a decrease next year of $0.00 per share.

* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.